1. Deal Values in Pharmaceutical and Healthcare Industry Has Decreased in August 2019
1.1. Pharmaceuticals & Healthcare, Deals Summary, August 2019
2. Pharmaceuticals & Healthcare, Global, Deal Summary,
2.1. Pharmaceuticals & Healthcare, Global, Deal Analysis, August 2019
2.2. Pharmaceuticals & Healthcare, Global, Major Deals, August 2019
2.2.1. Amgen to Acquire Rights to Otezla from Celgene for USD13.4 Billion
2.2.2. Permira Funds to Acquire Cambrex
2.2.3. Sosei Heptares Enters into Partnership with Takeda Pharma
2.2.4. Vertex Pharma to Acquire Semma Therapeutics for USD950 Million
2.2.5. Bayer to Acquire 59.2% Stake in BlueRock Therapeutics from Versant Venture
2.3. Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, August 2019
2.4. Pharmaceuticals & Healthcare, Global, by Type, Deal Values, August 2019
3. Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type
3.1. Pharmaceuticals & Healthcare, Global, M&A, August 2019
3.1.1. Top M&A Deals in August 2019
3.1.2. Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, March 2019 - August 2019
3.2. Pharmaceuticals & Healthcare, Global, Equity Offering Deals, August 2019
3.2.1. Top Equity Offering Deals in August 2019
3.2.2. Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, March 2019 - August 2019
3.3. Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, August 2019
3.3.1. Top PE/VC Deals in August 2019
3.3.2. Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, August 2019
3.3.3. Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2019
3.3.5. Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2016-August 2019
3.3.7. Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2019-August 2019
3.4. Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2019
3.5. Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, March 2019 - August 2019
3.6. Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), August 2019
3.6.1. Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, August 2019
3.7. Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2019 - August 2019
3.8. Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2019 - August 2019
3.9. Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), March 2019 - August 2019
3.10. Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2019 - August 2019
4. Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2019
4.1. Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2019
4.2. Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), August 2019
4.3. Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), March 2019 - August 2019
4.4. Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), March 2019 - August 2019
4.5. Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), March 2019 - August 2019
4.6. Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), March 2019 - August 2019
4.6.1. Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, August 2019
4.6.2. Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, August 2019
4.6.3. Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, August 2019
5. Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area
5.1. Pharmaceuticals & Healthcare, Global, Oncology Deals, August 2019
5.1.1. Oncology - Deals of the Month
5.2. Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, August 2019
5.2.1. Central Nervous System - Deals of the Month
5.3. Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, August 2019
5.3.1. Infectious Diseases - Deals of the Month
5.4. Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, August 2019
5.4.1. Cardiovascular - Deals of the Month
5.5. Pharmaceuticals & Healthcare, Global, Immunology Deals, August 2019
5.5.1. Immunology - Deal of the Month
5.6. Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, August 2019
5.6.1. Gastrointestinal - Deals of the Month
5.7. Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, August 2019
5.7.1. Metabolic Disorders - Deals of the Month
6. Deal Summary by Geography
6.1. Pharmaceuticals & Healthcare, North America Deals, August 2019
6.1.1. North America - Deals of the Month
6.2. Pharmaceuticals & Healthcare, Europe, Deals, August 2019
6.2.1. Europe - Deals of the Month
6.3. Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, August 2019
6.3.1. Asia-Pacific - Deals of the Month
6.3.2. Rest of the World - Deals of the Month
7. Pharmaceuticals & Healthcare, Global, Top Financial Advisors
7.1. Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, March 2019 - August 2019
7.2. Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, March 2019 - August 2019
8. Further Information
8.1. Methodology
8.2. About the Author
8.3. Contact Us
8.4. Disclosure information
8.5. Disclaimer
List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, August 2019
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), August 2019
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, August 2019
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2019 - August 2019
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, August 2019
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, August 2019
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, March 2019 - August 2019
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), August 2019
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2019 - August 2019
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2019 - August 2019
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), August 2019
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2019 - August 2019
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2019 - August 2019
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), March 2019 - August 2019
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), March 2019 - August 2019
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), August 2019
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2019 - August 2019
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), August 2019
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, August 2019
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, August 2019
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, August 2019
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
List of Figures
Figure 1: Pharmaceuticals & Healthcare, Number of Deals by Therapy Area, August 2019
Figure 2: Pharmaceuticals & Healthcare, Number of Licensing Deals By Payment Mode, March 2019 - August 2019
Figure 3: Pharmaceuticals & Healthcare, Number of Deals by Region, August 2019
Figure 4: Pharmaceuticals & Healthcare, Number of Deals by Type, August 2019
Figure 5: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 6: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), August 2019
Figure 7: Pharmaceuticals & Healthcare, Global, Deal Values (%), August 2019
Figure 8: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 9: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2019 - August 2019
Figure 10: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 11: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 12: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 13: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2019 - August 2019
Figure 14: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), August 2019
Figure 15: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), August 2019
Figure 16: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 17: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2019 - August 2019
Figure 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2019 - August 2019
Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2019 - August 2019
Figure 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2019 - August 2019
Figure 23: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2019 - August 2019
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2019 - August 2019
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 27: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2019 - August 2019
Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, March 2019 - August 2019
Figure 29: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), March 2019 - August 2019
Figure 30: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), August 2019
Figure 31: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 32: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 33: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 34: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 35: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 36: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 37: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 38: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 39: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 40: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 41: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 42: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), March 2019 - August 2019
Figure 43: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), March 2019 - August 2019